Taken together, this highlights BAP1's complex role as a tumour suppressor,118 whereby its high frequency of loss strongly implicates its involvement in driving PM onset, while in the mesothelial context inhibits anchorage‐independent growth (Figure 5F) and sensitises tumour cells to therapeutic intervention.45 The gene discussed is BAP1; the disease is neoplasm.